Singapore markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.75-0.61 (-5.89%)
At close: 04:00PM EDT
9.75 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.33B
Enterprise value 297.89M
Trailing P/E 5.92
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)29.83
Price/book (mrq)0.86
Enterprise value/revenue 6.77
Enterprise value/EBITDA 0.90

Trading information

Stock price history

Beta (5Y monthly) 0.50
52-week change 3-60.72%
S&P500 52-week change 323.76%
52-week high 325.37
52-week low 37.61
50-day moving average 39.67
200-day moving average 39.75

Share statistics

Avg vol (3-month) 3987k
Avg vol (10-day) 31.57M
Shares outstanding 5136.06M
Implied shares outstanding 6136.06M
Float 890.93M
% held by insiders 111.76%
% held by institutions 176.24%
Shares short (15 May 2024) 46.21M
Short ratio (15 May 2024) 46.5
Short % of float (15 May 2024) 47.47%
Short % of shares outstanding (15 May 2024) 44.57%
Shares short (prior month 15 Apr 2024) 45.15M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)-142.05%

Management effectiveness

Return on assets (ttm)-16.73%
Return on equity (ttm)-30.67%

Income statement

Revenue (ttm)79.6M
Revenue per share (ttm)0.59
Quarterly revenue growth (yoy)-10.50%
Gross profit (ttm)N/A
EBITDA -578.4M
Net income avi to common (ttm)-539.44M
Diluted EPS (ttm)-4.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.15B
Total cash per share (mrq)8.45
Total debt (mrq)121.08M
Total debt/equity (mrq)7.82%
Current ratio (mrq)12.90
Book value per share (mrq)11.39

Cash flow statement

Operating cash flow (ttm)-762.39M
Levered free cash flow (ttm)-612.25M